| 产品名称： | Streptococcus agalactiae Lehmann and Neumann |
|---|---|
| 商品货号： | TS150455 |
| Strain Designations： | 515, Type la |
| Isolation： | Neonate, cerebrospinal fluid |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Procedure |
| Preceptrol®： | no |
| Genome Sequenced Strain： | Yes |
| Type Strain： | no |
| Comments： | Genome sequencing strain |
| Medium： | ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor： | MJ Cieslewicz, CJ Baker |
| Special Collection： | NSF - Bacteriology |
| Year of Origin： | March, 1977 |
| References： | Tettelin H, et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc. Natl. Acad. Sci. USA. 102(39): 13950-13955, 2005. PubMed: 16172379 Wessels M, et al. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect. Immun. 61(11): 4760-4766, 1993. PubMed: 8406875 Baker CJ, et al. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.. J. Clin. Invest. 69: 394-404, 1982. PubMed: 7035495 |
| Cross References： | Nucleotide (GenBank) : AAJP01000000 Streptococcus agalactiae 515, whole genome shotgun sequencing project |
产品中心 Product Center
联系我们CONTACT US
-
0574-87917803
24小时服务热线 -
testobio@163.com
销售邮箱 -
浙江省宁波市高新区晶辉路866弄33号智造港E4幢3楼
地址
联系方式
-
章丽敏
17757489010 -
朱静
18067106081 -
李晴
18067408036 -
李晶晶
13375187189 -
周雪
13372109301
| 产品名称： | Streptococcus agalactiae Lehmann and Neumann |
|---|---|
| 商品货号： | TS150455 |
| Strain Designations： | 515, Type la |
| Isolation： | Neonate, cerebrospinal fluid |
| Biosafety Level： | 2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Product Format： | freeze-dried |
| Storage Conditions： | Frozen: -80°C or colder Freeze-Dried: 2°C to 8°C Live Culture: See Propagation Procedure |
| Preceptrol®： | no |
| Genome Sequenced Strain： | Yes |
| Type Strain： | no |
| Comments： | Genome sequencing strain |
| Medium： | ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood ATCC® Medium 44: Brain Heart Infusion Agar/Broth |
| Growth Conditions： | Temperature: 37°C Atmosphere: Aerobic |
| Name of Depositor： | MJ Cieslewicz, CJ Baker |
| Special Collection： | NSF - Bacteriology |
| Year of Origin： | March, 1977 |
| References： | Tettelin H, et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc. Natl. Acad. Sci. USA. 102(39): 13950-13955, 2005. PubMed: 16172379 Wessels M, et al. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharide-tetanus toxoid conjugate vaccine. Infect. Immun. 61(11): 4760-4766, 1993. PubMed: 8406875 Baker CJ, et al. Antibody-independent classical pathway-mediated opsonophagocytosis of type Ia, group B streptococcus.. J. Clin. Invest. 69: 394-404, 1982. PubMed: 7035495 |
| Cross References： | Nucleotide (GenBank) : AAJP01000000 Streptococcus agalactiae 515, whole genome shotgun sequencing project |
